Boston Scientific Neuromodulation Corporation recalls
Boston Scientific Neuromodulation Corporation is named on 10 recalls in Recall Relay's records since November 2023, from FDA (11 recalled products: FDA lists each product as its own recall); the most recent was September 30, 2026.
All 11 recalled products, newest first.
-
Class IIofficial
Boston Scientific Neuromodulation Corporation recalls Nalu TD2 Therapy Disc with firmwareTherapy Disc (TD) that powers and sends stimulation signals to an Implantable Pulse Generator (IPG), part of a neurostimulation system, has a firmware issue that causes the TD to attempt to restart, then fail, leading it to become non-functional, and if a secondary TD is unavailable, this may lead IPG to become non-functional, thus unable to inhibit transmission of pain signals.
-
Class Iofficial
Boston Scientific Neuromodulation Corporation recalls INFINION CX LEAD KITSpinal cord stimulation system lead body may be exposed to stress at the anchor site. This may result in high impedance measurements or lead fractures, which may lead to inadequate stimulation, additional intervention, including lead explant and replacement.
-
Class IIofficial
Boston Scientific Neuromodulation Corporation recalls Boston Scientific TCN Electrodes: REF: TCN-5Reusable electrodes may not meet expected performance levels.
-
Class IIofficial
Boston Scientific Neuromodulation Corporation recalls Boston Scientific Model SC-4318Sterile anchors my lack sterility assurance.
-
Class IIofficial
Boston Scientific Neuromodulation Corporation recalls Boston Scientific CSK Electrodes: REF: CSK-TC10Reusable electrodes may not meet expected performance levels.
-
Class IIofficial
Boston Scientific Neuromodulation Corporation recalls Intracept Access InstrumentsIntraosseous nerve ablation system instruments may have sterile barrier breach of the outer tray seal, which may introduce a risk of sterility breach, and if breached could lead to severe infection.
-
Class IIofficial
Boston Scientific Neuromodulation Corporation recalls Vercise Deep Brain Stimulation Systems Surgical Implant ManualWire break(s) have occurred in rechargeable deep brain stimulation implantable pulse generators, implanted in the submuscular pectoral location. Wire breaks prevent successful stimulation, thus requiring device removal/replacement and users may experience high monopolar impedances, undesired sensation, loss of therapy, return of symptoms and/or Bluetooth connectivity challenges.
-
Class IIofficial
Boston Scientific Neuromodulation Corporation recalls Burr Hole Cover KitResistance and difficulties could occur while closing the retaining clip locking mechanism, which is part of a burr hole cover kit, which is part of a Deep Brain Stimulation (DBS) system, which may lead to procedural delay, or lead-migration-which may require additional surgery.
-
Class IIofficial
Boston Scientific Neuromodulation Corporation recalls Superion IDS Kit Superion Indirect Decompression System 8MMAs a result of a comprehensive product performance review it was determine that the device and instruments are not consistently meeting expected performance levels. Issues include breakage of the instruments and implant/device.
-
Class IIofficial
Boston Scientific Neuromodulation Corporation recalls WAVEWRITER ALPHA: Model: SC-1216Spinal Cord Stimulation (SCS) Implantable Pulse Generator (IPG) may experience routine system check during IPG charging, which may cause device reset, which may lead to transient loss of stimulation; patients may experience undesired sensations when therapy turns off for approx. 10-15 seconds and then back on, which may lead patient to request surgical intervention for replacement or revision.
-
Class IIofficial
Boston Scientific Neuromodulation Corporation recalls Vercise Genus Deep Brain Stimulation (DBS) Implantable Pulse Generator IPG: R16 IPG KITDeep Brain Stimulation (DBS) Implantable Pulse Generator (IPG) may experience routine system check during IPG charging, which may cause device reset. The device reset could lead transient loss of stimulation; patients may experience undesired sensations, transient worsening of movement disorder symptoms, which may lead patient to request surgical intervention for replacement or revision.
This page groups recalls by the company name the agency printed, so it can include different companies with similar names, and a recall may name a store or distributor rather than the maker. It counts the recalls in Recall Relay's records, not a company's whole history; an FDA recall that lists several products counts once. Open a recall to see its details and the agency's official notice, which is always the final word. Recall Relay isn't affiliated with any agency or with the companies named here.
Severity labels say where they come from: “official” is the agency's own class, “advisory” is based on the agency's safety warning, and “est. risk” is Recall Relay's estimate from the hazard description, not an agency classification.
Hear about the next one
Recall Relay can email you when a new recall mentions Boston Scientific Neuromodulation Corporation or any words you choose. Start with a free key (no card needed), then set up alerts on your account page.
Get recall alerts